A study finds that nearly 65% of users of weight loss drugs like Ozempic quit due to high costs and limited insurance coverage. Understanding the challenges in affordability and access is crucial to improve health outcomes.

Recent Medicare changes now allow more seniors to access continuous glucose monitors, improving diabetes management at low cost.